haloperidol decanoate has been researched along with Anochlesia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barcelos, RC; Benvegnú, DM; Boufleur, N; Bürger, ME; Emanuelli, T; Müller, LG; Pase, C; Reckziegel, P | 1 |
| Egan, MF; Hyde, TM; Kleinman, JE; Weinberger, DR; Wing, LL; Wyatt, RJ | 1 |
| Kurachi, M; Kurachi, T; Murata, M; Sun, YJ; Suzuki, M | 1 |
3 other study(ies) available for haloperidol decanoate and Anochlesia
| Article | Year |
|---|---|
Effects of omega-3 essential fatty acids (omega-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Fatty Acids, Omega-3; Haloperidol; Male; Maze Learning; Memory Disorders; Movement Disorders; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Time Factors | 2010 |
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 1995 |
Expression of Fos protein in the limbic regions of the rat following haloperidol decanoate.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Catalepsy; Haloperidol; Immunohistochemistry; Limbic System; Male; Nerve Tissue Proteins; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar | 1998 |